BLUE: bluebirdbio.com Company Sales Revenue

bluebird bio Inc. - graphic logo of issuer BLUE

The automation of cellular manipulations ensures process sterility at bluebird bio, Inc. (BLUE). The company specializes in blood gene therapy for the treatment of thalassemia and anemia, leveraging immense market potential. The company's historical sales levels confirm current trends, where the value of 0.10 expresses the state of the metric. The implementation of robotic bioreactors during viral vector propagation minimizes the risk of human error.

BLUE - bluebird bio, Inc. Revenue and Sales Volume over the range 07/04/2022 - 06/07/2025

Analytical breakdowns for Bluebird Bio (BLUE)

- current price and projected stock value:
- market capitalization information:
Summary company analysis:bluebird bio, Inc.
Original product of bluebird bio Inc.

For bluebird bio, Inc., sales revenue serves as a key indicator of gene therapy commercialization, measuring the volume of cash flows from the sale of innovative drugs. Analyzing this sales revenue allows for an assessment of how geopolitical instability and the disruption of biological supply chains impact the business's actual ability to generate capital amid limited international cooperation.

Analysis of competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Gross Revenue Phio Pharmaceuticals (PHIO)|MBIO: Company Sales|Company Sales Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Revenue|APDN - Company Gross Revenue|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales